M. LetÃcia Ribeiro, CHC - Enerca
M. LetÃcia Ribeiro, CHC - Enerca
M. LetÃcia Ribeiro, CHC - Enerca
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
LABORATORY DIAGNOSIS OF RARE<br />
ANAEMIAS<br />
Hereditary RBC membrane defects<br />
3rd European Symposium on Rare Anaemias<br />
M. Leticia <strong>Ribeiro</strong><br />
Madrid, Nov 2010<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Red Blood Cells<br />
RBCs are biconcave under<br />
physiological conditions<br />
Their shape changes when navigating<br />
narrow blood vessels or confined<br />
spaces in tissues and organs<br />
The ability of red cell to maintain its<br />
discoid shape, shape,<br />
elasticity and<br />
deformability in circulation, under<br />
constant mechanical shear and stress<br />
forces, is attributed to its lipid layer<br />
and proteins<br />
Kightley Media<br />
CELLS alive<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Erythrocyte Membrane Proteins<br />
Vertical Interaction<br />
Horizontal Interaction<br />
Lux SE, Palek J:<br />
Disorders of the Red Cell Membrane<br />
A deficiency of, or a dysfunction in, any one of these membrane<br />
proteins can weaken or destabilize the cytoskeleton, resulting<br />
in abnormal red cell morphology and a shorter life span -<br />
Hemolysis<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Red Blood Cell Membrane Disorders<br />
congenital hemolytic anemias characterized by clinical,<br />
laboratory and genetic heterogeneity<br />
Hereditary Spherocytosis<br />
Hereditary Elliptocytosis<br />
Hereditary Pyropoikilocytosis<br />
Hereditary Southeast Asian Ovalocytosis<br />
Hereditary Stomatocytosis<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Hereditary Stomatocytosis<br />
a group of dominantly inherited hemolytic anemias<br />
with abnormal membrane permeability to<br />
univalent cations<br />
Hydrocytosis – Overhydrated stomatocytosis<br />
Xerocytosis – Dehydrated stomatocytosis<br />
Cryohydrocytosis<br />
Familial Pseudohyperkaliemia<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Hereditary Elliptocytosis<br />
By Rex Graham<br />
Normal Pr 4.1 absent<br />
Skeletal network<br />
electron mycroscopy, by Yawata et al<br />
The main defects in HE are protein 4.1 deficiency and spectrin<br />
mutations, which can be detected as spectrin variants<br />
The clinical severity in HE depends on the amount of spectrin<br />
variant incorporated into the skeleton, and the closer the<br />
mutation is to the junction where dimers associate, the less<br />
stable is the tetramer<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Hereditary Elliptocytosis<br />
Prevalence<br />
1:5000 among Caucasians (Protein ( Protein 4.1 deficiency)<br />
deficiency<br />
1:100 in certain African countries (Spectrin ( Spectrin mutations)<br />
mutations)<br />
In the majority of HE individuals the anemia is very mild<br />
and often the elliptocytes are detected during a routine<br />
analysis<br />
Hb 7-9 g/dL<br />
Retic 11%<br />
Individuals Splenomegaly with nonhemolytic HE<br />
do not Protein<br />
have splenomegaly, splenomegaly<br />
4.1 deficiency<br />
, and<br />
their reticulocyte counts are slightly<br />
elevated to normal<br />
HE due to complete protein 4.1 deficiency is a severe<br />
hemolytic disease<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Pyropoikilocytosis<br />
HPP is a severe form of HE - patients often<br />
present with severe hemolytic anemia during the<br />
newborn period<br />
These patients are either homozygous or<br />
compound heterozygous for spectrin<br />
mutations<br />
HPP can also be due to the co-inheritance<br />
of the low-expression allele Spα LELY<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Pyropoikilocytosis<br />
D R S<br />
Hb g/dL<br />
MCV fL<br />
MCH pg<br />
M<strong>CHC</strong> %<br />
PBS<br />
14.1<br />
92<br />
29<br />
31<br />
Elliptocytes<br />
3º day of life<br />
Hb g/dL 11.5<br />
Bil mol/L 145<br />
Anisopoikylocytosis<br />
13.3<br />
13.4<br />
3 years old<br />
Normal<br />
αLELY αV/41 Spectrin α 28 Arg-His (CGT-CAT)<br />
α(nt 1857 Leu-Val; CTA-GTA) Intron 45, nt 12 (C-T)<br />
80<br />
30<br />
37<br />
96<br />
27<br />
29<br />
Normal<br />
Elliptocytes<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Southeast Asian Ovalocytosis<br />
Dominant inheritance<br />
SAO AE1 gene contains a deletion of 9 CD encoding amino<br />
acids 400-408, at the boundary of the cytoplasmic and<br />
membrane domains, in cis with Lys56Glu substitution<br />
SAO red cells are rigid and hiperstable<br />
Hemolysis is mild or absent<br />
Fem, 27 years old<br />
Pregnant<br />
Origin: East Timor<br />
Hb g/dL 11.1<br />
MCV fL 89<br />
MCH pg 31<br />
M<strong>CHC</strong> % 34.5<br />
RDW % 17<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Hereditary Spherocytosis<br />
Membrane lesions involving the vertical interactions<br />
between skeleton and lipid bilayer lead to vesiculation of the<br />
unsupported surface components, causing a progressive<br />
reduction in membrane surface area. area<br />
The red cell shape changes from a flexible, deformable biconcave<br />
disc to a spherical poorly deformable red cell – the<br />
spherocyte<br />
The severity of hemolysis depends on the contents of Spectrin<br />
from Lux SE, Palek J: Disorders of the Red Cell Membrane, Blood Principles and Pratice of Hematology<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Hereditary Spherocytosis<br />
The commonest cause of inherited chronic hemolysis in Northern<br />
Europe and North America - Prevalence 1:5000 to 1:2000<br />
Inheritance<br />
Dominant ≈ 2/3<br />
Non-dominant ≈ 1/3 de novo or recessive<br />
In Italian population the occurency of de novo dominant mutations in HS<br />
patients with normal parents is 6xs more common than recessive<br />
mutations (Miraglia del G. et al, 2001)<br />
The abnormal RBC morphology in HS is due to a deficiency of,<br />
or a disfunction in, Spectrin, Ankyrin, Band 3 and/or Protein 4.2<br />
The Spα LEPRA allele (Low Expression Prague) is prevalent among nondominant<br />
HS (Boivin, et al 1993, Dhermy, et al 2000, Wichterle, et al<br />
1996)<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
HS – clinical features<br />
Clinical severity of HS varies from symptom-free carrier to severe<br />
hemolysis. Most individuals have mild to moderate disease<br />
The diagnosis may be made at any time of life<br />
Clinical manifestations:<br />
Neonatal jaundice / Intermittent jaundice<br />
Splenomegaly<br />
depending on the co-inherency of Gilbert syndrome<br />
Anemia<br />
Post-infection hemolytic anemia<br />
Aplastic crises (Parvovirus B19 infection)<br />
Excellent response to splenectomy<br />
Family history<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
HS Laboratory Characteristics<br />
Anemia<br />
Reticulocytes ↑<br />
M<strong>CHC</strong> ↑<br />
% Hyperdense cells ↑<br />
Spherocytes<br />
Unconjugated ↑<br />
DAT neg<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
120 fL<br />
60 fL<br />
Hyperchromic RBC<br />
Normal HS<br />
28 g/dL<br />
41 g/dL<br />
Methods: CBC+RET, CBC+RET,R<br />
CELL-DYN ® SAPPHIRE<br />
% hyperchromic RBC (<strong>CHC</strong> > 41g/dL)<br />
Samples:<br />
21 HS<br />
51 controls<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
HS - hyperchromic RBC<br />
Statistical significant<br />
correlation between<br />
HS and % HPR RBC (>2.5%)<br />
Test Mann Whitney (U)<br />
Statistical significant association between<br />
HS and the typical scatter <strong>CHC</strong> Distribution (Test χ2 )<br />
U=1071<br />
p
HS - Diagnosis<br />
1. Screening tests<br />
Osmotic fragility<br />
AGLT (Pink test)<br />
Cryohemolysis<br />
Flow Cytometric (EMA)<br />
Ektacytometry<br />
2. Protein membrane<br />
electrophoresis<br />
3. Molecular studies<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Osmotic Fragility<br />
Spherocytes take up less water in a<br />
HS<br />
hypotonic solution before rupturing than<br />
entire do normal curve erythrocytes<br />
“shifted to the right”, or<br />
OF most gives of an it in indication the normal of the range volume-to- with a<br />
surface tail of fragile ratio cells<br />
curve Abnormal within OF normal invariably range indicates in 10-20% of<br />
abnormal cases red cells<br />
after OF 24h within incubation, the normal abnormalities range does not more<br />
mean marked, normal but red still cells with some falsenegative<br />
Practical Haematology, Dacie and Lewis, 10th Edition, 2006<br />
Parpart, et al 1947<br />
HS<br />
AIHH<br />
PK def.<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Acidified Glicerol Lyses-Time Test<br />
AGLT<br />
Time taken for 50%<br />
hemolysis of a blood sample<br />
in a buffered hypotonic<br />
saline-glycerol mixture<br />
Cells with a high volume-to-surface area ratio resist swelling<br />
for a shorter time than normal cells<br />
AGLT50:<br />
: HS 25’’-150’’; normal >30’<br />
AGLT 50<br />
HS: sensitivity 98.3%; specificity 91.1% (Hoffman et al)<br />
Short AGLT 50 in AIHA, HPFH, PK deficiency, severe G6PD,<br />
pregnant women (1:3), CRF on dialysis (some), MDS<br />
Special attention to the pH and osmolality<br />
PINK TEST (Bucx, et al 1988) is a modified AGLT<br />
Zanella, et al 1980<br />
ctr<br />
HS<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Cryohemolysis<br />
Dependent on factors related to red cell<br />
membrane molecular defects<br />
Normal 3-15%, HS >20%<br />
Increased hemolysis in HS and some CDAII<br />
and SAO<br />
For HS: sensitivity 95%; specificity 96% (Iglauer et<br />
al, 1999)<br />
Streichman and Gescheidt, 1998<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Flow Cytometric (Dye Binding) Test<br />
Measures the fluorescent intensity of intact red cells labeled with<br />
Eosin-5-Maleimide (EMA)<br />
EMA binds to Band 3 Lys430 (80%), Rh blood group proteins, Rh<br />
glycoprotein and CD47 (30%)<br />
EMA binding Flow Cytometric test is efficient for HS<br />
screening whatever the protein involved<br />
Reduced fluorescence in CDAII,<br />
cryohydrocytosis, SAO<br />
Fluorescence intensity graded reduction<br />
HPP< HS< HE≤ normal controls<br />
Each lab should set the reference range<br />
and cut-off values<br />
King, et al 2000<br />
F Girodon at al 2007<br />
For HS: sensitivity 92.7%; specificity 99.1% Gallagher M. Letícia PG, <strong>Ribeiro</strong>, Jarolim <strong>CHC</strong> P
Racio<br />
Diagnosis of HS by Flow Cytometry<br />
Department of Haematology - Centro Hospitalar de Coimbra<br />
n=181 - routine samples with normal hematological parameters;<br />
n=183 n= 183 - samples from previously diagnosed patient with Hemolytic<br />
Anemias (HA) of different types<br />
Mean ratios and the 95% CI for each group<br />
1.40<br />
1.20<br />
1.00<br />
0.80<br />
0.60<br />
1.08<br />
AIHA<br />
1.10<br />
nSHA<br />
0.98 <br />
1.00<br />
HMA<br />
Controls<br />
n=364<br />
<br />
HS<br />
0.71<br />
<br />
1.07 <br />
0.96<br />
Other HA<br />
HE<br />
Conclusions:<br />
HS have significantly different<br />
values from HA of other<br />
aetiology, in special AIHA<br />
HE values are quite similar to<br />
controls<br />
HS due to primary band 3<br />
deficiency and HS due to<br />
ankyrin/spectrin reduction have<br />
no significant different values<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Osmotic gradient Ektacytometry<br />
A laser diffraction viscometer that measures red<br />
cell deformability at constant shear stress as<br />
a continuous function of suspending<br />
osmolality (hypotonic to hypertonic)<br />
Results are plotted as a deformability curve,<br />
which has a distinct shape for each type of<br />
abnormal red cells tested<br />
Distinct deformability curves for red cells from<br />
patients with HS, HE, HPP, stomatocytosis<br />
and sickle disease<br />
Clark, et al 1983<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
HS diagnosis - Screening tests<br />
Take into account the :<br />
sensitivity and specificity of the test<br />
complexity of the protocol<br />
cost of instruments and its maintenance<br />
More specific tests:<br />
Cryohemolysis – 95%<br />
EMA binding - 99 %<br />
(level IIa/III evidence, Grade B recommendation # )<br />
Confirmation of diagnosis may be necessary if the<br />
screening tests produce an equivocal or borderline<br />
result<br />
# Guidelines for the Diagnosis and Management of Hereditary Spherocytosis. General Haematology Task Force of the British Committee<br />
for Standards in Haematology, 2004. (modified from Iolascon et al 1998))<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Protein Membrane Electrophoresis SDS-PAGE<br />
SDS-PAGE Electrophoresis detects the qualitative and<br />
quantitative membrane proteins alterations<br />
Densitometry of the protein bands on the gel gives an overall<br />
profile of spectrins, spectrins,<br />
ankyrin, ankyrin,<br />
band 3 and protein 4.2<br />
Single ankyrin deficiency is not detectable in a non-<br />
splenectomised HS patient with reticulocytosis<br />
Laemmli<br />
α-spectrin -spectrin<br />
β-<br />
ankirin<br />
band 3<br />
prot.4.1<br />
prot.4.2<br />
actin<br />
G3PD<br />
stomatin<br />
Fairbanks<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Quantitation of membrane proteins<br />
Quantitation of membrane proteins is not necessary for the<br />
majority of HS cases<br />
Very mild or HS carrier states (≈10% of HS patients) may<br />
not have a detectable membrane protein deficiency<br />
In CDAII - a more compact and faster migrating Band 3<br />
In SAO - slower migrating Band 3<br />
SDS-PAGE is recommended when:<br />
the clinical phenotype is more severe than predicted from the<br />
red cell morphology<br />
the red cell morphology is more severe than predicted from<br />
parental blood films where one parent is known to have HS<br />
the diagnosis is not clear prior to splenectomy (MCV>100 fL)<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Hereditary Spherocytosis<br />
SM<br />
Normal<br />
Band 3 Coimbra<br />
488 (GTG - ATG) Val-Met<br />
Band 3 Mondego<br />
147 (CCT-TCT) Pro-Ser<br />
Band 3 Montefiori<br />
40(GAG-AAG) Glu-Lis<br />
Hb. g/dL<br />
MCV fL<br />
16.4<br />
99<br />
MCH pg<br />
M<strong>CHC</strong> %<br />
35<br />
34<br />
Spherocytes -<br />
Band N3<br />
Protein 4.2 N<br />
8.0<br />
94<br />
32<br />
34<br />
8.3<br />
88<br />
29<br />
33<br />
13,2<br />
98<br />
36<br />
36<br />
11.7<br />
83<br />
28<br />
34<br />
+++ +++<br />
-<br />
Additive effects of two unequally expressed<br />
↓ 39 ↓ 40<br />
N<br />
AE1 mutant alleles can aggravate the<br />
↓ 38 ↓ 36<br />
N<br />
clinical features of an affected individual<br />
+<br />
↓ 20<br />
↓ 18<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Molecular studies<br />
Almost 95% 95 of the HS-associated mutations identified were<br />
private or sporadic occurrences<br />
Knowledge of the gene mutation does not influence the<br />
clinical management of the patient<br />
Analysis of membrane protein genes<br />
to establish the genetic basis of variable clinical<br />
expressions among affected family members<br />
to confirm recessive or de novo dominant mutations<br />
when both parents are apparently normal<br />
for Prenatal diagnosis<br />
Prenatal diagnosis in families at risk of having a<br />
child with a very severe form of HS<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Family with dominant HS<br />
Hb g/dL 13.2 15.6<br />
MCV fL 94 95<br />
M<strong>CHC</strong> % 37 38<br />
Ret % ? ?<br />
Spherocytes ++ ++<br />
Band 3 ↓ 20% ↓ 21%<br />
Prot 4.2 ↓ 17% ↓ 18%<br />
Heterozygous Band 3 Coimbra<br />
AE1488 (GTG→ATG) (GTG ATG) Val→Met Val Met<br />
2 years before the couple had a<br />
stillborn baby (36 weeks of gestation)<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Family with dominant HS<br />
Hb g/dL 5.2<br />
MCV fL 147<br />
MCH pg 49<br />
M<strong>CHC</strong> % 49<br />
Erythroblasts x10 9 /L 102<br />
Platelets x10 9 /L 43<br />
Bil total mmol/L 99<br />
Bil unconj mmol/L 79<br />
Metabolic acidosis<br />
Hydropsis Fetalis<br />
36 weeks of gestation<br />
Laemmli 5% -15%<br />
NB ctr<br />
ctr<br />
Band 3<br />
Prot 4.2<br />
Homozygous Band 3 Coimbra<br />
AE1488 (GTG→ATG) (GTG ATG) Val→Met Val Met<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
BSS - homozygous<br />
↓<br />
↓<br />
Father - heterozygous<br />
Prenatal Diagnosis<br />
Band 3 Coimbra<br />
488 (GTG→ATG)<br />
(GTG ATG)<br />
Fetus - heterozygous<br />
↓<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Flow chart for the diagnosis of HS<br />
Family History of HS;<br />
typical clinical & laboratory features<br />
No further<br />
investigations needed<br />
Dominant inheritance<br />
Patient presenting Hemolytic Anemia<br />
Variable clinical severity<br />
in different family members<br />
Search for co-inheriting<br />
hematological disorders<br />
β-Thalassemia or<br />
Sickle Cell Disease<br />
None<br />
Atypical blood film, ?<br />
Recent infection; no family history of HS<br />
Screen proband family<br />
for abnormal RBCs<br />
HS RBCs indicated<br />
in proband & sibling<br />
Normal test<br />
results<br />
Not membrane<br />
SDS-PAGE for<br />
protein defect ? Thalassemia<br />
? CDA ? MDS<br />
DNA analysis for low-expression allele (mainly αSp)<br />
Recessive or non-dominant inheritance<br />
in proband with no family history<br />
Guidelines for the Diagnosis and Management of Hereditary Spherocytosis. General Haematology Task Force of<br />
the British Committee for Standards in Haematology, 2004. (modified from Iolascon et al M. 1998)) Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
References<br />
1. Guidelines for the Diagnosis and Management of Hereditary Spherocytosis. P.H.B.<br />
Bolton-Maggs, R. F. Stevens, N.J. Dodd, M-J. King, G. Lamont, Pl Tittensor, On behalf<br />
of the General Haematology Task Force of the British Committee for Standards in<br />
Haematology, 2004<br />
2. Red Cell Membrane Disorders, Patrick G. Gallagher, Hematology 2005, The American<br />
Society of Hematology<br />
3. Practical Haematology, Dacie and Lewis, 10th ed. 2006 Churchill Livingstone<br />
4. Hematology of Infancy and Childhood, Nathan and Oski's, Sixth Edition by David G.<br />
Nathan, Stuart H. Orkin, A. Thomas Look, David Ginsburg<br />
5. Cryohemolysis test as a diagnostic tool for hereditary spherocytosis, A. Iglauer D.<br />
Reinhardt W. Schröter A. Pekrun, Ann Hematol (1999) 78: 555–557<br />
6. Anaemia, a defective cytoskeleton and cation permeability, May-Jean King,<br />
International Blood Group, Reference Laboratory, Southmead, Bristol, Biomedical<br />
Science Congress<br />
7. Diagnostic utility of the pre-incubated acidified glycerol lysis test in haemolytic and<br />
non-haemolytic anaemias.Hoffmann JJ, Swaak-Lammers N, Breed WP, Strengers JL.<br />
Eur J Haematol. 1991 Nov;47(5):367-70<br />
8. Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test<br />
for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and<br />
protein electrophoresis. Girodon F, Garçon L, Bergoin E, Largier M, Delaunay J,<br />
Fénéant-Thibault M, Maynadié M, Couillaud G, Moreira S, Cynober. T. Br J Haematol.<br />
2008 Feb;140(4):468-70<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>
Unidade de Anemias Congénitas<br />
Centro Hospitalar de Coimbra<br />
Celeste Bento<br />
Helena Almeida<br />
Elizabete Cunha<br />
Janet Pereira<br />
Umbelina Rebelo<br />
Luís Relvas<br />
www.chc-hematologia.org<br />
M. Letícia <strong>Ribeiro</strong>, <strong>CHC</strong>